BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16674307)

  • 21. Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: In vitro and in vivo studies.
    Koç A; Finkenzeller G; Elçin AE; Stark GB; Elçin YM
    J Biomater Appl; 2014 Nov; 29(5):748-60. PubMed ID: 25062670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homogeneous chitosan-PLGA composite fibrous scaffolds for tissue regeneration.
    Shim IK; Lee SY; Park YJ; Lee MC; Lee SH; Lee JY; Lee SJ
    J Biomed Mater Res A; 2008 Jan; 84(1):247-55. PubMed ID: 17607738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis.
    Cleland JL; Duenas ET; Park A; Daugherty A; Kahn J; Kowalski J; Cuthbertson A
    J Control Release; 2001 May; 72(1-3):13-24. PubMed ID: 11389981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia.
    Simón-Yarza T; Tamayo E; Benavides C; Lana H; Formiga FR; Grama CN; Ortiz-de-Solorzano C; Kumar MN; Prosper F; Blanco-Prieto MJ
    Int J Pharm; 2013 Oct; 454(2):784-90. PubMed ID: 23639291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
    Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
    Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation.
    Ji W; Yang F; Seyednejad H; Chen Z; Hennink WE; Anderson JM; van den Beucken JJ; Jansen JA
    Biomaterials; 2012 Oct; 33(28):6604-14. PubMed ID: 22770568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
    Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
    J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.
    Patil SD; Papadmitrakopoulos F; Burgess DJ
    J Control Release; 2007 Jan; 117(1):68-79. PubMed ID: 17169457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.
    Chung YI; Tae G; Hong Yuk S
    Biomaterials; 2006 Apr; 27(12):2621-6. PubMed ID: 16360204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vascularization of poly-lactic-co-glycolic acid knitted mesh/collagen-chitosan hybrid scaffold].
    Wang XG; Han CM; You CG; Zheng YR; Li QY; Zhang LP
    Zhonghua Shao Shang Za Zhi; 2011 Aug; 27(4):260-4. PubMed ID: 22097301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of porous poly(D,L-lactic-co-glycolic acid) sponges fabricated by supercritical CO2 gas-foaming method as a scaffold for three-dimensional growth of Hep3B cells.
    Zhu XH; Lee LY; Jackson JS; Tong YW; Wang CH
    Biotechnol Bioeng; 2008 Aug; 100(5):998-1009. PubMed ID: 18551526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres.
    Borselli C; Ungaro F; Oliviero O; d'Angelo I; Quaglia F; La Rotonda MI; Netti PA
    J Biomed Mater Res A; 2010 Jan; 92(1):94-102. PubMed ID: 19165799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor-loaded poly(lactic-co-glycolic acid) microspheres-induced lateral axonal sprouting into the vein graft bridging two healthy nerves: nerve graft prefabrication using controlled release system.
    Karagoz H; Ulkur E; Kerimoglu O; Alarcin E; Sahin C; Akakin D; Dortunc B
    Microsurgery; 2012 Nov; 32(8):635-41. PubMed ID: 22821743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects.
    Ruhé PQ; Hedberg-Dirk EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
    Tissue Eng; 2006 Apr; 12(4):789-800. PubMed ID: 16674292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan-hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds.
    Mohandas A; Anisha BS; Chennazhi KP; Jayakumar R
    Colloids Surf B Biointerfaces; 2015 Mar; 127():105-13. PubMed ID: 25660093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue engineered esophagus scaffold constructed with porcine small intestinal submucosa and synthetic polymers.
    Fan MR; Gong M; Da LC; Bai L; Li XQ; Chen KF; Li-Ling J; Yang ZM; Xie HQ
    Biomed Mater; 2014 Feb; 9(1):015012. PubMed ID: 24457267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering.
    Murphy WL; Peters MC; Kohn DH; Mooney DJ
    Biomaterials; 2000 Dec; 21(24):2521-7. PubMed ID: 11071602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.
    Zhong Y; Zhang L; Ding AG; Shenderova A; Zhu G; Pei P; Chen RR; Mallery SR; Mooney DJ; Schwendeman SP
    J Control Release; 2007 Oct; 122(3):331-7. PubMed ID: 17706831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factor release from a chemically modified elastomeric poly(1,8-octanediol-co-citrate) thin film promotes angiogenesis in vivo.
    Sharma AK; Bury MI; Fuller NJ; Rozkiewicz DI; Hota PV; Kollhoff DM; Webber MJ; Tapaskar N; Meisner JW; Lariviere PJ; Destefano S; Wang D; Ameer GA; Cheng EY
    J Biomed Mater Res A; 2012 Mar; 100(3):561-70. PubMed ID: 22162300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.